Ascension St. John clinical research institute joined the ACTIV-2 clinical trial to investigate two different antibodies to treat patients very early in the illness. According…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.